1 / 76

THE USE OF ANALGESICS, SEDATIVE MEDICATIONS PAIN, SEDATION IN CHILDREN

THE USE OF ANALGESICS, SEDATIVE MEDICATIONS PAIN, SEDATION IN CHILDREN. Compiled by Tina M. Slusher, MD University of Minnesota Contributions from: JOHN BERKENBOSH, M.D. University of Louisville CHERI LANDERS, M.D. University of Kentucky LYNNE W. COULE, M.D. Medical College of Georgia

zaide
Download Presentation

THE USE OF ANALGESICS, SEDATIVE MEDICATIONS PAIN, SEDATION IN CHILDREN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. THE USE OF ANALGESICS, SEDATIVE MEDICATIONS PAIN, SEDATION IN CHILDREN Compiled by Tina M. Slusher, MD University of Minnesota Contributions from: JOHN BERKENBOSH, M.D. University of Louisville CHERI LANDERS, M.D. University of Kentucky LYNNE W. COULE, M.D. Medical College of Georgia DAVID ROSEN, M.D. West Virginia University STEVE BARNES, M.D. Rush University

  2. Conflict of Interest • I have nothing to disclose

  3. Which of the following is true regarding pain management? • 1. Pain management affects wound healing • 2. PTSD is not related to acute pain management • 3. Neonates don’t feel pain

  4. Importance of Effective Pain Control • Untreated pain has psychological effects • Exacerbates injury and may  mortality • Contributes to delayed wound healing • Contributes to development of chronic pain and PTSD Bowman et al J of Trauma &Acute Care Surgery 2011

  5. Non-pharmacological pain control-audiovisual distraction • Decreased pain • Increased cooperation • Decreased time of procedure Swiss Med Wkly. 2008 Oct 4;138(39-40):579-84. The efficacy of non-pharmacological methods of pain management in school-age children receiving venepuncture in a paediatric department: a randomized controlled trial of audiovisual distraction and routine psychological intervention. Wang ZX, Sun LH, Chen AP. J Prev Med Hyg. 2012 Mar;53(1):44-8. Distraction techniques in children during venipuncture: an Italian experience. Bagnasco A, Pezzi E, Rosa F, Fornonil L, Sasso L.

  6. Anesthesia Myths cont. • Wrong!! Children do feel pain and neonates likely feel even more pain • Pain transmission begins @2weeks gestation w/development of skin and mouth sensory neurons • Appearance of pain inhibitory apparatus begins at about 32 wks gestation

  7. <20 years ago common belief was than infants did not feel pain and no anesthesia was used even during surgery • In 1992, a trial showed deep anesthesia during cardiac surgery↓ physiologic stress responses and mortality & gave convincing evidence of importance of adequate analgesia for newborn infants • Untreated pain may have undesirable long-term consequences, even after fairly minor procedures Nelson’s textbook

  8. Analgesia/Sedation Myths Concerns about respiratory depression make pain control impossible in children Wrong again!!! • Need to titrate and Need to monitor • Easy to overshoot in < 6 months • Caveat in the < 6 month old infant • Opioids can cause apnea prior to pain relief • Neonates may not get good pain relief from morphine but is commonly used in neonates-more studies needed.

  9. Analgesia/Sedation Myths • True addiction rarely happens with appropriate pain control • “Addiction” • Addiction vs. Tolerance vs. Dependance

  10. Addiction • A common fear voiced by health care workers • Includes a psychological “need” or craving along with physical withdrawal symptoms if medication is discontinued • People in real pain DON’T become addicted as long as medication titrated to pain

  11. Tolerance • The same dose of medication no longer has the same effect as when first started • More commonly occurs in patients on long term continuous infusions of sedatives or analgesics rather than intermittent dosing especially if not titrated to the clinical situation • There are currently NO medications to which tolerance will not develop

  12. Dependence • Removing medication results in withdrawal symptoms • To avoid withdrawal, may need to wean sedative or analgesic or change to long acting agents such as methadone or clonidine when patient has been on the medication for 1 week or more

  13. ASSESSING PAIN • JCAHO – pain as 5th vital sign (mandate) • Developmental and cultural barriers • Ability to verbalize • Cultural attitudes to pain coping/treatment • Non-painful contributors to “pain-like” behaviors

  14. Assessing Pain cont. • Autonomic measures • Heart rate • Blood pressure • Behavioral or combined behavioral-physiologic scales (e.g. facial expression, limb movement ± heart rate & blood pressure

  15. What is Analgesia? “Relief of the perception of pain without intentional production of a sedated state. Altered mental status may be a secondary effect of medications administered for this purpose.”

  16. WHO Golden Rules of Pain Management 1. By the Clock • Regular scheduling ensures steady blood level • PRN results in cycles of pain often leading to increased pain med needs 2. With the child • Regular pain assessment using appropriate scales

  17. Scales available on line, standard textbooks or hospital.

  18. MANAGING PAIN • 1990 – WHO pain management ladder • Stepwise approach, based on anticipated severity • 1° developed for cancer pain, adapted for all acute pain • Outpatient and inpatient applications • Enteral and intravenous routes encouraged

  19. WHO LADDER MILD PAIN: • NSAIDS, Acetaminophen ± adjuvants MODERATE PAIN: • NSAID or acetaminophen ± weak opioid (oxy, hydro, codeine) ± adjuvants • IV opioids with scheduled NSAID or acetamin • PCA vs CI vs intermittent • Regional Anesthetic techniques SEVERE PAIN: • IV opioids (PCA/CI) ± adjuvants • Regional Anesthetic techniques ± adjuvants

  20. ANALGESIANSAIDS • Ibuprofen: • Onset – 60-90 min • Peak – 2-4 hrs • Duration – 6-8 hrs • 80% oral bioavailability • Hepatic metabolism via oxidation, excreted in urine 8-10mg/kg/dose q 6-8hr PO or PR

  21. NSAIDS cont. • Naproxen ≥12yo to ≤65yo 200mg q6-8hr • Diclofenac-start in adult 50mg tid • All NSAIDS have similar analgesic properties if used in equi-analgesic dose and many of the same side effects

  22. ANALGESIA NSAIDS cont. Ketorolac • Only use IV if patient unable to take po NSAID • At equianalgesic dosing no more effective than ibuprofen but has greater side effects • 0.5-1 mg/kg q6h, po/IV/IM • Onset – 10/30 min, peak – 40-60/90-180 min • Duration – ~6 hrs • Similar kinetics in infants, children, adolescents • Time limited regimen

  23. Codeine • Poor analgesic properties • Genetic variation means may lead to toxic levels i.e ultra-rapid metabolism can result in toxic accumulation of morphine • Don’t use if at all possible

  24. Oxycodone • Management of moderate-severe pain • Comes as immediate and sustained release

  25. Morphine • Opioid • Advantages • Analgesia • Less expensive than fentanyl • Disadvantages • no amnesia, anxiolysis • Histamine release - wheezing, hypotension • Urinary retention • Longer onset than fentanyl

  26. ANALGESIAMORPHINE • Dose/route • IV/IM - 0.05-0.1mg/kg/dose - onset 2-3 min, duration 3-4 hr • infusion 0.01-0.04 mg/kg/hr • po - 0.2-0.5 mg/kg - slow - onset 30-60 minutes • onset – <5 min/1 hr • Peak – 20 min/1-2 hr • Duration – 3-5 hr Rectal Morphine also option 0.2 mg/kg/dose

  27. ANALGESIAMORPHINE • More widely available than fentanyl • Advantages: -Cheap • Disadvantages: • pruritus, hypotension, bronchospasm, sedation, urinary retention

  28. ANALGESIAFENTANYL • Synthetic opioid, ~ 100X more potent than morphine • More “hemodynamically friendly” than morphine • 100x more potent than morphine • shorter duration than morphine • onset in 2-3 min, lasts 30-60 min • less histamine release than morphine

  29. Fentanyl • Disadvantages: • no amnesia • “Steel chest” or “rigid chest” phenomenon • more likely with large bolus dose • Treat with reversal of fentanyl or paralyzation or midazolam

  30. Fentanyl cont. • Dose/route: • IV - sedation/analgesia - 1-3 mcg/kg/dose - anaesthesia - 5-10 mcg/kg/dose - infusion - 3-5 mcg/kg/hr • Oral - 5-10 mcg/kg • IN-1.5-2.0 mcg/kg

  31. ANALGESIAFENTANYL • IV/transmucosal • onset – <2 min/5-15 min • Peak – <5 min/20 min • Duration – 30-60 min/1-2 hr • Transmucosal – 25% buccal (rapid), 75% GI (slow)

  32. Tramadol • Non-opioid analgesia but works on opioid receptors w/weak opioid • Don’t mix w/strong opoid like morphine or pain make worsen • Central inhibition of seroton and non-epinephrine • Causes some inhibition of ascending pain pathway • PO • Dose 1-2 mg/kg/dose q 4-6 hours (max 400mg/day)

  33. Pethidine • Bad choice but sometimes only one available • Agonist-Antagonist • Metabolite can build up and cause respiratory depression w/out adequate pain control • Often underdosed • Dose 0.3-1mg/kg/dose q6hours

  34. Ketamine • Low dose ketamine may be alternative for pain control • See latter section on ketamine for more information

  35. Sucrose/Breastfeeding in Neonates • Sucrose with or without a pacifier can be used for both pain and stress control in the neonate • Breastfeeding + sucrose or glucose may be best alternative? • However, recent article in Lancet questions whether oral sucrose actually does reduce pain because although pain score was lower there was no difference in nociceptive or spinal withdrawal activity (Slater R et al, Lancet. 2010;376:1225-1232

  36. ANALGESIANALAXONE (NARCAN) • Reverses sedation, analgesia, respiratory depression • NO agonist activity so NO risk sedation/respiratory depression with overdoses • Use has decreased as a reversal agent because of risk of re-sedation • Dose: 0.1 mg/kg IV/IM • use incremental doses (0.005-0.01 mg/kg) to avoid adverse • Adverse: • short half-life, resedation/depression • opioid withdrawal (infants of addicted mothers) • agitation, seizures, N+V

  37. Naloxone in Low Doses • Used to treat itching associated w/narcotics as low-dose continuous infusion • Used to Rx nausea unresponsive to anti-emetics • Can be given po to treat constipation from narcotics unresponsive to other bowel regimes [(1mg/mL) 4 mL po BID to TID in older children/adults; 1-2mL po BID-TID in younger children]

  38. Pediatric Procedural Sedation Tina M. Slusher, MD Associate Professor of Pediatrics

  39. WHY SEDATE?

  40. SEDATIONRATIONALE • Anxiety • underlying illness • separation from parents • transport environment and transfers • Ability to perform procedure • Safety - risks of motion (invasive) • Motion interference (i.e. radiologic)

  41. What Presedation Assessment Do You NEED?

  42. PRESEDATION ASSESSMENTHISTORY • Brief and Targeted: • Procedure being done and why • Pertinent past history • underlying medical conditions • prior sedations/anaesthetics and reactions to them • Underlying airway issues • Present medications - consider possible interactions • Allergies - get specifics - not all reactions are allergies-include food allergies as well • Family history of anaesthetic reactions • NPO Status • Determine specific sources of anxiety

  43. Patient’s NPO status • <6 mo 2 hours for clears and 4 hours for breast milk and 6 hours for formula or food • >6 mo 2 hours for clears and 6 hours for food unless diabetic or GER or other situations at increased risk for delayed emptying

  44. PRESEDATION ASSESSMENTPHYSICAL EXAM • Vital signs including baseline SaO2 • General evaluation looking for evidence • illnesses, toxicity • volume depletion • obesity • Airway exam • micrognathia/macroglossia, tonsils/adenoids • ability to open mouth well • Lung exam • Wheezing, air exchange • Cardiac exam • Unrecognized heart disease • Volume status • Neurologic status • Ability to protect airway • Ability to cooperate with exam.

  45. ASA Physical Status Class I: Healthy patient Class II: Systemic disease-well controlled Class III: Severe systemic disease Class IV: Severe systemic disease that is a constant threat to life Class V: Moribund / not expected to survive without surgery

  46. How do you determine the best agent? What questions do you ask? What do you need to know?

  47. AGENT DETERMINATION • Relative need for anxiolysis vs analgesia • Depth of sedation desired/required • Duration of procedure • Degree of patient/family anxiety • prior experiences with procedures  sedation • Underlying medical conditions • include family history of reactions to anaesthetics • airway - obstruction, oral anatomy, CLDz • hemodynamic - volume status, cardiac function

  48. Sedation and Pain Control are synonymous. • True • False

  49. SEDATION DOES NOT EQUAL PAIN CONTROL Some drugs like barbiturates actually increase pain by inhibiting neural pathways 

  50. SEDATIONDEFINTIONS Mild (Conscious) Sedation • minimally depressed level of consciousness • ability to independently maintain airway patency retained • respond appropriately to physical or verbal stimulation Deep (Unconscious) Sedation • controlled state of decreased or lost consciousness • risk of partial/complete loss of airway protection/patency • partial/complete inability to respond appropriately General Anaesthesia • medically controlled state of unconsciousness • complete loss of airway protection and responsiveness

More Related